BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 25668557)

  • 21. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study.
    Parienti JJ; Mégarbane B; Fischer MO; Lautrette A; Gazui N; Marin N; Hanouz JL; Ramakers M; Daubin C; Mira JP; Charbonneau P; du Cheyron D;
    Crit Care Med; 2010 Apr; 38(4):1118-25. PubMed ID: 20154599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.
    Bleyer AJ; Mason L; Russell G; Raad II; Sherertz RJ
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):520-4. PubMed ID: 16018426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials.
    Buetti N; Ruckly S; Lucet JC; Mimoz O; Souweine B; Timsit JF
    Intensive Care Med; 2019 Dec; 45(12):1774-1782. PubMed ID: 31624854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial.
    Schoot RA; van Ommen CH; Stijnen T; Tissing WJ; Michiels E; Abbink FC; Raphael MF; Heij HA; Lieverst JA; Spanjaard L; Zwaan CM; Caron HN; van de Wetering MD
    Eur J Cancer; 2015 Sep; 51(14):2031-8. PubMed ID: 26188849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial.
    Slobbe L; Doorduijn JK; Lugtenburg PJ; El Barzouhi A; Boersma E; van Leeuwen WB; Rijnders BJ
    PLoS One; 2010 May; 5(5):e10840. PubMed ID: 20520776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of ethanol lock therapy in pediatric patients on long-term parenteral nutrition.
    Pieroni KP; Nespor C; Ng M; Garcia M; Hurwitz M; Berquist WE; Kerner JA
    Nutr Clin Pract; 2013 Apr; 28(2):226-31. PubMed ID: 23232749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.
    León C; Alvarez-Lerma F; Ruiz-Santana S; González V; de la Torre MV; Sierra R; León M; Rodrigo JJ
    Crit Care Med; 2003 May; 31(5):1318-24. PubMed ID: 12771597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study.
    Sofroniadou S; Revela I; Smirloglou D; Makriniotou I; Zerbala S; Kouloubinis A; Samonis G; Iatrou C
    Semin Dial; 2012 May; 25(3):344-50. PubMed ID: 22074188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
    Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
    J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
    Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.
    Moore CL; Besarab A; Ajluni M; Soi V; Peterson EL; Johnson LE; Zervos MJ; Adams E; Yee J
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1232-9. PubMed ID: 24970874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.
    Filippi L; Pezzati M; Di Amario S; Poggi C; Pecile P
    Pediatr Crit Care Med; 2007 Nov; 8(6):556-62. PubMed ID: 17914310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease.
    Abdelkefi A; Torjman L; Ladeb S; Othman TB; Achour W; Lakhal A; Hsairi M; Kammoun L; Hassen AB; Abdeladhim AB
    J Clin Oncol; 2005 Nov; 23(31):7864-70. PubMed ID: 16258088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tunneled catheter infections in patients on hemodialysis--one center experience].
    Resić H; Ajanović S; Kukavica N; Corić A; Masnić F; Bećiragić A
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():17-21. PubMed ID: 23513412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial.
    Broom J; Woods M; Allworth A; McCarthy J; Faoagali J; Macdonald S; Pithie A
    Scand J Infect Dis; 2008; 40(5):399-406. PubMed ID: 18418801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy of an interdialytic "ethanol 40% v/v - enoxaparin 1000 U/mL" lock solution to prevent tunnelled catheter infections in chronic hemodialysis patients: a multi-centre, randomized, single blind, parallel group study.
    Aniort J; Piraud A; Adda M; Perreira B; Bouiller M; Fourcade J; Guerraoui A; Kalbacher E; Krumel T; Moragues HL; Thibaudin D; Vela CG; Vernin G; Weclawiak H; Bernard L; Heng AE; Souweine B
    BMC Nephrol; 2019 Apr; 20(1):149. PubMed ID: 31039759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.